Home › Funds › Two Sigma Investments › AKBA
Two Sigma Investments position in AKBA
AKEBIA THREAPEUTICS INC · Health Care
Latest position (Q2 2026)2.44M sh
Reported value held$2.78M
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 97.17K | $220.00K | New |
| Q2 2022 | 213.55K | $75.00K | New |
| Q3 2022 | 537.36K | $170.00K | Add |
| Q4 2022 | 374.29K | $215.97K | Reduce |
| Q2 2023 | 216.21K | $197.84K | New |
| Q3 2023 | 27.46K | $31.31K | Reduce |
| Q4 2023 | 185.40K | $229.90K | Add |
| Q3 2024 | 24.85K | $32.80K | New |
| Q4 2025 | 90.62K | $145.90K | New |
| Q1 2026 | 1.30M | $1.80M | Add |
| Q2 2026 | 2.44M | $2.78M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding AKBA
- Vanguard Group 16.02M sh · $25.79M · Q4 2025
- BlackRock Inc 19.99M sh · $22.78M · Q2 2026
- AQR Capital Management 9.15M sh · $10.43M · Q2 2026
- Geode Capital Management 6.73M sh · $7.67M · Q2 2026
- Goldman Sachs Group 3.69M sh · $4.21M · Q2 2026
- Millennium Management 3.20M sh · $3.64M · Q2 2026
- Charles Schwab Investment Management 2.30M sh · $2.62M · Q2 2026
- Northern Trust Corp 2.16M sh · $2.46M · Q2 2026
- Fidelity Management & Research (FMR) 1.87M sh · $2.13M · Q2 2026
- UBS Group AG 1.37M sh · $1.57M · Q2 2026
- Renaissance Technologies 1.22M sh · $1.40M · Q2 2026